Congressionally Directed Medical Research Programs
OrganisationROR
Trials
Collaborator, Phase 2, Not yet recruiting, 55 people, 13 Apr 2026
Collaborator, Phase 2, Not yet recruiting, 104 people, 24 Feb 2026
Collaborator, Phase 1/2, Recruiting, 25 people, 18 May 2023
Collaborator, Phase 1/2, Completed, 17 people, 12 Jan 2022
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
Collaborator, Early phase 1, Recruiting, 220 people, 16 Sept 2021
Collaborator, Phase 4, Terminated, 4 people, 9 Oct 2017
Collaborator, Phase 2, Completed, 63 people, 19 Apr 2016
Collaborator, Phase 1/2, Completed, 60 people, 28 Sept 2015
Collaborator, Phase 2, Completed, 60 people, 25 Dec 2014
Collaborator, Phase 2, Completed, 60 people, 20 Oct 2010
Sources: clinicaltrials.gov
Funded papers
OC210060, OC230086, 1 Oct 2026
8 Sept 2026
Metabolically Active but Dysfunctional: The Impact of Senescent Cells and SASP
CA230221, 24 Aug 2026
Nerve injury-on-a-chip uncovers extracellular matrix and mitochondrial roles in axonal regeneration
FY19W81XWH2010207, 11 Aug 2026
MD240021, 26 Mar 2026
TX230133, 25 Mar 2026
Non-invasive ovulation tracking enables genetic engineering in wild rodents
17 Feb 2026
GW180044, 4 Feb 2026
Age-Associated Dysregulation of Postsynaptic Mitochondria Perturbs Reinnervation Kinetics
W81XWH2010336, W81XWH2110491, 1 Jan 2026
1 Dec 2025
Optimized Synthetic Flavonols Support Senescence Clearance and Lung Fibrosis Resolution
HT9425-24-1-0208-01, 4 Sept 2025
13 Aug 2025
OC220011, 24 Jan 2024
W81XWH-18-1-0118,W81XWH-19-1-0236, 7 May 2020
Sources: api.crossref.org